2-hydroxy-3-pinonyl pyrimidine pH-sensitive fluorescent probe as well as preparation method and application thereof

CN118978512AActive Publication Date: 2024-11-19NANJING FORESTRY UNIV
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202411073791.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-06
Publication Date
2024-11-19
Estimated Expiration
2044-08-06

AI Technical Summary

Technical Problem

这些荧光探针的检测效果不仅容易受到竞争性离子、反应时间等外界因素的干扰,且都是单一的检测模式,不能特异性地对酸性和碱性情况进行检测,特别是无法做到同时靶向两种细胞器(溶酶体和线粒体)

Benefits of technology

[0026] Beneficial effects: Compared with the prior art, the present invention uses 2-hydroxy-3-pinone as raw material to prepare the 2-hydroxy-3-pinonyl pyrimidine compound 4-(9-ethyl-6-(pyridine). - 4-yl)-9H-carbazol-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7- Cyclomethylenequinazoline-8-olnant Anisotropy identifies acidic pH and alkaline pH. Under acidic conditions, as the pH value in the system continues to decrease, the fluorescence color of the solution changes from blue to yellow; under alkaline conditions, as the pH value in the system continues to increase , the blue fluorescence of the solution gradually weakens, and can be used as a fluorescent probe for measuring pH. It has many advantages such as convenient synthesis, good selectivity, and high sensitivity, and has good application prospects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118978512A_ABST
    Figure CN118978512A_ABST
Patent Text Reader

Abstract

The invention discloses a 2-hydroxy-3-pinonyl pyrimidine pH sensitive type fluorescent probe as well as a preparation method and application of the 2-hydroxy-3-pinonyl pyrimidine pH sensitive type fluorescent probe. The preparation method comprises the following steps: by taking 2-hydroxy-3-pinone as a raw material, carrying out aldol condensation reaction on the 2-hydroxy-3-pinone and 6-bromo-9-ethyl-9H-carbazole-3-formaldehyde, so as to obtain 4-((6-bromo-9-ethyl-9H-carbazole-3-yl) methylene)-2-hydroxy-2, 6, 6-trimethyl bicyclo [3.1. 1] hept-3-ketone; the preparation method comprises the following steps: carrying out cyclization reaction on 4-((6-bromine-9-ethyl-9H-carbazole-3-yl) methylene)-2-hydroxy-2, 6, 6-trimethyl bicyclo [3.1. 1] hept-3-ketone and 4-hydroxybenzamidine hydrochloride, so as to prepare 4-(6-bromine-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6, 6, 8-trimethyl-5, 6, 7, 8-tetrahydro-5, 7-methylene quinazoline-8-alcohol; the preparation method comprises the following steps: carrying out a coupling reaction on 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6, 6, 8-trimethyl-5, 6, 7, 8-tetrahydro-5, 7-methylene quinazoline-8-alcohol and 4-pyridine boric acid, so as to obtain the 4-(9-ethyl-6-(pyridine-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6, 6, 8-trimethyl-5, 6, 7, 8-tetrahydro-5, 7-methylene quinazoline-8-alcohol, and carrying out a coupling reaction on the 4-(9-ethyl-6-(pyridine-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6, 6, 8 and 2, 7-bridged methylene quinazoline-8-alcohol is used as a raw material. The 4-(9-ethyl-6-(pyridine-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6, 6, 8-trimethyl-5, 6, 7, 8-tetrahydro-5, 7-methylene quinazoline-8-alcohol can specifically recognize an acidic pH value and an alkaline pH value, and under the acidic condition, along with the continuous reduction of the pH value in a system, the fluorescence color of a solution is changed from blue to yellow; under the alkaline condition, the blue fluorescence of the solution is gradually weakened along with the continuous increase of the pH value in the system, and the compound can be used as a fluorescent probe for determining the pH value, has the advantages of convenience in synthesis, good selectivity, high sensitivity and the like, and has a good application prospect.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of fine organic synthesis, and relates to a 2-hydroxy-3-pinone pyrimidine pH-sensitive fluorescent probe and a synthesis method and application thereof. Background Art

[0002] The homeostasis of the intracellular environment is a necessary condition for cells to maintain normal physiological functions and even for the body to maintain normal life activities. The homeostasis of pH plays a vital role in the growth and development of organisms. The pH value of lysosomes ranges from 4.5 to 5.5, and contains a variety of hydrolases, such as proteases, nucleases, phosphatases, etc., which are used to decompose biological macromolecules such as proteins, nucleic acids, and polysaccharides. The function of lysosomes is affected by the pH of lysosomes. Under normal circumstances, abnormal lysosomal pH can lead to diseases such as cell dysfunction, neurodegenerative diseases, and lysosomal storage disorders. The acidic environment of lysosomes is caused by ATP pumping protons into the lumen, and ATP is produced by mitochondria. Mitochondria exist in most eukaryotic cells and play an important role in cell metabolism, such as regulating the redox state of cells, producing reactive oxygen free radicals (ROS) to degrade pathogens, regulating calcium homeostasis, participating in cell apoptosis, and regulating stem cells. Mitochondria are slightly alkaline with a pH of about 8. Mitochondrial dysfunction can lead to changes in mitochondrial pH, which is often present in diabetes, cardiovascular diseases, and neurodegenerative diseases.

[0003] In recent years, many fluorescent probes for measuring pH have been reported. These fluorescent probes are mainly designed and synthesized from traditional fluorophores such as coumarin, rhodamine, and naphthalimide. The detection effects of these fluorescent probes are not only easily interfered by external factors such as competitive ions and reaction time, but also have a single detection mode and cannot specifically detect acidity and alkalinity, especially cannot simultaneously target two organelles (lysosomes and mitochondria). Therefore, it is of great significance to design and develop a pH fluorescent probe targeting lysosomes and mitochondria that can simultaneously measure acidity and alkalinity with high sensitivity, high selectivity, and quantitative rapidity. Summary of the invention

[0004] Purpose of the invention: In view of the deficiencies in the prior art, the purpose of the present invention is to provide a 2-hydroxy-3-pinonyl pyrimidine compound to meet the use requirements. Another purpose of the present invention is to provide a method for synthesizing the above-mentioned 2-hydroxy-3-pinonyl pyrimidine compound. Another purpose of the present invention is to provide an application of the compound.

[0005] Technical solution: To achieve the above-mentioned invention object, the technical solution adopted by the present invention is:

[0006] 2-Hydroxy-3-pinonyl pyrimidine compound is 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol, and its structural formula is:

[0007]

[0008] The method for synthesizing 2-hydroxy-3-pinone pyrimidine type compounds comprises the following process steps:

[0009] 1) using 2-hydroxy-3-pinone as a raw material, and carrying out an aldol condensation reaction with 6-bromo-9-ethyl-9H-carbazole-3-carboxaldehyde to obtain 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one;

[0010] 2) 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one is subjected to a cyclization reaction with 4-hydroxybenzamidine hydrochloride to prepare 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol;

[0011] 3) 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol is subjected to coupling reaction with 4-pyridineboronic acid to prepare 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol.

[0012] In step 1), 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one, the specific preparation method comprises:

[0013] (1) 1.1-1.5 mmol 2-hydroxy-3-pinene, 1-1.36 mmol 6-bromo-9-ethyl-9H-carbazole-3-carboxaldehyde, 3-4.08 mmol potassium tert-butoxide and 50-68 mL tert-butanol were sequentially added into a 100 mL dry three-necked flask, refluxed for 12 h, followed by TLC monitoring, and the reaction was stopped after the reaction was complete;

[0014] (2) After removing tert-butyl alcohol from the reaction solution by distillation under reduced pressure, ethyl acetate was added, and the mixture was washed with saturated brine until neutral. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product of 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one;

[0015] (3) The crude product of 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one was separated by silica gel column (ethyl acetate / petroleum ether=1 / 5, v / v) to obtain 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one.

[0016] In step 2), the specific preparation method of 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazoline-8-ol comprises:

[0017] (1) 3-3.5 mmol 4-hydroxybenzamidine hydrochloride, 1.5-1.75 mL 30% sodium hydroxide solution, 1-1.17 mmol 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one, and 6-7 mL dimethyl sulfoxide were sequentially added into a 50 mL dry three-necked flask and heated under reflux for reaction for 12 h;

[0018] (2) After the reaction solution is cooled to room temperature, ethyl acetate is added, and the mixture is washed with saturated brine until neutral. The organic phase is dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product of 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol;

[0019] (3) The crude product of 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol was separated by silica gel column (ethyl acetate / petroleum ether=1 / 1, v / v) to obtain 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol.

[0020] In step 3), the specific preparation method of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxypropyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazoline-8-ol is as follows:

[0021] (1) 2-2.4 mmol 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol, 6-7.2 mmol 4-pyridineboric acid, 0.2-0.24 mmol tetrakis(triphenylphosphine)palladium, 9-10.8 mmol potassium carbonate, and 50-60 mL 1,4-dioxane / water solution were sequentially added into a 100 mL dry three-necked flask, and heated under reflux for reaction for 20 h under nitrogen protection;

[0022] (2) After the reaction solution was distilled under reduced pressure to remove 1,4-dioxane / water solution, ethyl acetate was added, and the mixture was washed with saturated brine until neutral. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol;

[0023] (3) The crude product of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol was separated by silica gel column (dichloromethane / methanol=35 / 1, v / v) to obtain 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol.

[0024] The application of the 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-bridged methylenequinazoline-8-ol in fluorescent probes.

[0025] The compound 4-(9-ethyl-6(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-bridged methylquinazolin-8-ol, under acidic conditions, as the pH value in the system continues to decrease, the fluorescence color of the solution changes from blue to yellow; under alkaline conditions, as the pH value in the system continues to increase, the blue fluorescence of the solution gradually weakens, which shows that the probe can sensitively detect pH value and can be used as a fluorescent probe for measuring pH.

[0026] Beneficial effects: Compared with the prior art, the 2-hydroxy-3-pinone-based pyrimidine compound 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-bridged methylquinazoline-8-ol prepared by using 2-hydroxy-3-pinone as a raw material can specifically identify acidic pH and alkaline pH. Under acidic conditions, as the pH value in the system continues to decrease, the fluorescence color of the solution changes from blue to yellow; under alkaline conditions, as the pH value in the system continues to increase, the blue fluorescence of the solution gradually weakens. The invention can be used as a fluorescent probe for measuring pH, has many advantages such as convenient synthesis, good selectivity, high sensitivity, etc., and has good application prospects. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 is the fluorescence intensity of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol acting on different pH under acidic conditions;

[0028] Figure 2 is the fluorescence intensity of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol acting on different pH under alkaline conditions;

[0029] Figure 3 It is the fluorescence intensity of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazol-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol interacting with different ions. DETAILED DESCRIPTION

[0030] The present invention will be further described below in conjunction with specific embodiments.

[0031] Example 1

[0032] Preparation of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol

[0033] The preparation route of 4-(9-ethyl-6-(pyridin--4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazoline-8-ol is as follows:

[0034]

[0035] The specific steps include:

[0036] 1) Preparation of 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one:

[0037] 1.1-1.5mmol 2-hydroxy-3-pinene, 1-1.36mmol 6-bromo-9-ethyl-9H-carbazole-3-carboxaldehyde, 3-4.08mmol potassium tert-butoxide and 50-68mL tert-butanol were added to a 100mL dry three-necked flask in sequence, refluxed for 12h, followed by TLC monitoring, and the reaction was stopped after the reaction was complete. The reaction solution was distilled under reduced pressure to remove tert-butanol, and then ethyl acetate was added, washed with saturated brine until neutral, and the organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product of 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one. The crude product of 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one was separated by silica gel column (ethyl acetate / petroleum ether=1 / 5, v / v) to obtain 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one with a yield of 62.5% and a purity of 98.3%; 1 H NMR (600 MHz, DMSO-d 6)δ: 8.47(d, J=1.8Hz, 1H), 8.28-8.19(m, 1H), 7.69-7.62(m, 2H), 7.61-7.57( m, 2H), 7.50 (dd, J=8.6, 1.7Hz, 1H), 5.35 (s, 1H), 4.43 (d, J=7.2Hz, 2H), 3.46 ( d, J=6.1Hz, 1H), 2.58 (t, J=10.4, 6.0Hz, 1H), 2.10 (d, J=6.1Hz, 1H), 1.86 (d, J=10.4Hz, 1H), 1.42 (s, 3H), 1.37 (s, 3H), 1.29 (d, J=7.1Hz, 3H), 0.86 (s, 3H). 13 C NMR (150 MHz, DMSO-d 6 )δ: 201.86, 140.22, 139.38, 139.15, 133.48, 128.94, 128.68, 126.57, 124.43, 123.72, 122.93, 121.87, 1 11.88, 111.82, 110.04, 75.27, 51.05, 43.18, 40.40, 37.74, 28.97, 27.49, 25.74, 24.33, 14.13.HRMS: m / z calculated for C 25 H 26 BrNO 2 [M+Na] + , 474.1045; found, 474.1050.

[0038] 2) Preparation of 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazoline-8-ol:

[0039] 3-3.5mmol 4-hydroxybenzamidine hydrochloride, 1.51.75mL 30% sodium hydroxide solution, 1-1.17mmol 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one, and 6-7mL dimethyl sulfoxide were added to a 50mL dry three-necked flask in sequence, and heated under reflux for 12h. After the reaction solution was cooled to room temperature, ethyl acetate was added, and it was washed several times with saturated brine. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product of 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol. The crude product of 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol was separated by silica gel column (ethyl acetate / petroleum ether=1 / 1, v / v) to obtain 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol with a yield of 38.7% and a purity of 98.4%; 1 H NMR (600 MHz, DMSO-d 6 )δ: 9.84 (d, J=2.4Hz, 1H), 8.41-8.36 (m, 2H), 8.30-8.24 (m, 1H), 7.75 (dd, J=10.4, 8.5Hz, 1H), 7.69-7.64 (m, 1H), 7.62-7.57 (m, 1H), 7.51 (ddd, J=8.3, 7.1, 1.2Hz, 1H), 7.25 (t, J=7.6Hz, 1H), 6.92-6.88 (m, 2H), 5.29 (d, J=3.9Hz, 1H), 4.52-4.48 (m, 2H), 3.17 (dt, J=12.0, 5.8Hz, 1H), 2.61-2.56 (m, 1H), 2.21 (td, J=6.0, 2.5Hz, 1H ), 1.91 (t, J = 9.5Hz, 1H), 1.68 (s, 3H), 1.45-1.43 (m, 3H), 1.35 (dt, J = 9.1, 7.1Hz, 3H), 0.78 (d, J = 14.0Hz, 3H). 13 C NMR (150 MHz, DMSO-d 6)δ: 169.64, 169.58, 168.54, 162.97, 162.42, 162.21, 161.71, 161.68, 160.04, 1 60.02, 153.12, 140.55, 140.49, 140.23, 139.23, 134.97, 131.64, 131.57, 129.90 , 129.87, 129.65, 129.49, 129.46, 129.36, 129.28, 128.95, 128.83, 128.21, 127.41, 126.64, 124.62, 123.82, 122.64, 122.54, 122.37, 121.73, 121.63, 121.12, 11 9.61, 115.72, 115.69, 111.85, 111.82, 109.82, 109.55, 109.24, 73.84, 73.82, 73.52, 53.11, 52.93, 52.90, 44.95, 44.54, 43.62, 42.93, 42.87, 40.41, 40.28, 40.1 4, 40.00, 39.86, 39.72, 39.58, 37.79, 37.60, 31.53, 31.42, 27.57, 27.55, 27.31, 26.76, 26.26, 24.33, 24.28, 24.13, 22.52, 14.42, 14.23, 14.18, 14.14.HRMS: m / z calculated for C 32 H 30 Bn 3 O 2 [M+H] + , 568.1601; found, 568.1600.

[0040] 3) Preparation of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol:

[0041] 2-2.4 mmol 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-bridged methylquinazoline-8-ol, 6-7.2 mmol 4-pyridineboric acid, 0.2-0.24 mmol tetrakis(triphenylphosphine)palladium, 9-10.8 mmol potassium carbonate, and 50-60 mL of 1,4-dioxane / water solution were sequentially added into a 100 mL dry three-necked flask and heated under reflux for reaction for 20 h under nitrogen protection. The reaction solution was distilled under reduced pressure to remove 1,4-dioxane / water solution, ethyl acetate was added, and the mixture was washed with saturated brine until neutral. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-bridged methylquinazoline-8-ol. The crude product of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol was separated by silica gel column (dichloromethane / methanol=35 / 1, v / v) to obtain 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol; the yield was 44.8% and the purity was 97.8%; 1 HNMR (600 MHz, DMSO-d 6 )δ: 9.86 (s, 1H), 8.84 (s, 1H), 8.63 (d, J = 5.2Hz, 2H), 8.55 (s, 1H), 8.41 (d, J = 8.3Hz, 2H), 7.97 (d, J = 8 .8Hz, 1H), 7.87 (d, J=5.3Hz, 2H), 7.78 (q, J=8.5, 7.3Hz, 2H), 7.58 (d, J=8.5Hz, 1H), 6.92 (d, J=8.3Hz ,2H), 5.32(s, 1H), 4.54(q, J=7.1Hz, 2H), 3.18(t, J=5.7Hz, 1H), 2.60(dt, J=10.8, 5.7Hz, 1H), 2.21( t, J=5.9Hz, 1H), 1.93 (d, J=9.8Hz, 1H), 1.70 (s, 3H), 1.43 (s, 3H), 1.38 (t, J=7.2Hz, 3H), 0.77 (s, 3H). 13 C NMR (150 MHz, DMSO-d 6)δ: 169.62, 162.40, 161.74, 160.04, 150.56, 148.16, 141.09, 140.80, 131.67, 129.91, 129.45, 129.40, 128.56, 127.89, 125.41, 123.47, 1 22.87, 122.25, 121.52, 119.85, 115.69, 110.53, 109.50, 73.82, 52.91, 44.57, 42.89, 37.83, 31.41, 27.56, 26.76, 24.30, 14.25. HRMS: m / z calculated for C 37 H 34 N 4 O 2 [M+H] + ,567.2762;found,567.2760.

[0042] Example 2

[0043] 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol was dissolved in PBS / DMF (v / v=9 / 1) buffer to prepare 1×10 - 5 The probe solution with a concentration of M was prepared by adding hydrochloric acid to a PBS / DMF (v / v=9 / 1) buffer solution to prepare a solution with a pH of 1.35-12.57. The fluorescence emission spectra of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol at different pH values ​​were measured using a standard titration method using a fluorescence spectrophotometer. Figure 1 , Figure 2 The results show that under acidic conditions ( Figure 1 ), as the pH value in the system continued to decrease, the fluorescence emission intensity of the probe at 422nm weakened, and a new emission peak gradually increased at 514nm, and the solution changed from blue to yellow fluorescence. The pKa value of the probe was 4.28. Under alkaline conditions ( Figure 2 ), as the pH value in the system continued to increase, the fluorescence emission intensity of the probe at 422nm gradually decreased, and no new emission peak appeared, the blue fluorescence of the solution gradually weakened, and the pKa value of the probe was 8.24. This shows that the probe can sensitively detect pH value.

[0044] Example 3

[0045] 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol was dissolved in PBS / DMF (v / v=9 / 1) buffer to prepare 1×10 - 5 M concentration of probe solution, various ions were dissolved in PBS / DMF (v / v = 9 / 1) buffer to prepare 5 × 10 -4 M concentration solution, and adjust the pH to 3.5, 7.5, and 11.5. The fluorescence emission spectra of different ion pairs 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol were measured by standard titration method under fluorescence spectrophotometer, such as Figure 3 The results show that the fluorescence of the probe solution changes significantly under different pH conditions, and the addition of other ions such as Al 3+ , Ca 2+ , Cu 2+ 、Co 2+ , Fe 3+ 、Ni + Mg 2+ 、Cd 2+ , K + 、Na + 、Zn 2+ ,La 3+ , Mn 2+ , Ba 2+ , Fe 2+ , HPO 4 2 -CrO 7 2- 、SO 3 2- 、SCN - ,PO 4 3- 、NO 2 - , HS - , CO 3 2- 、SO 4 2- Br - 、F - ,I - ,AcO - , HCO 3 - 、NO 3 - The fluorescence intensity ratio of the solution under acidic conditions (F514nm / F 422nm ) and alkaline conditions, the fluorescence intensity of the solution at 422 nm did not change significantly, indicating that the probe can specifically detect pH.

Claims

1. A 2-hydroxy-3-pinonyl pyrimidine pH-sensitive fluorescent probe, characterized in that: The probe is 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazoline-8-ol, and its structural formula is:

2. The method for preparing the 2-hydroxy-3-pinonyl pyrimidine pH-sensitive fluorescent probe according to claim 1, characterized in that: The steps include: 1) using 2-hydroxy-3-pinone as a raw material, and carrying out an aldol condensation reaction with 6-bromo-9-ethyl-9H-carbazole-3-carboxaldehyde to obtain 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one; 2) 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one is subjected to cyclization reaction with 4-hydroxybenzamidine hydrochloride to prepare 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol; 3) 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol is subjected to coupling reaction with 4-pyridineboronic acid to prepare 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol.

3. The method for preparing the 2-hydroxy-3-pinonyl pyrimidine pH-sensitive fluorescent probe according to claim 2, characterized in that: In step 1), the specific preparation method of 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one is as follows: (1) 1.1-1.5 mmol 2-hydroxy-3-pinene, 1-1.36 mmol 6-bromo-9-ethyl-9H-carbazole-3-carboxaldehyde, 3-4.08 mmol potassium tert-butoxide and 50-68 mL tert-butanol were sequentially added into a 100 mL dry three-necked flask, refluxed for 12 h, followed by TLC monitoring, and the reaction was stopped after the reaction was complete; (2) After removing tert-butyl alcohol from the reaction solution by distillation under reduced pressure, ethyl acetate was added, and the mixture was washed with saturated brine until neutral. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product of 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one; (3) The crude product of 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one was separated by silica gel column (ethyl acetate / petroleum ether=1 / 5, v / v) to obtain 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one.

4. The method for preparing the 2-hydroxy-3-pinonyl pyrimidine pH-sensitive fluorescent probe according to claim 2, characterized in that: In step 2), the specific preparation method of 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazoline-8-ol is as follows: (1) 3-3.5 mmol 4-hydroxybenzamidine hydrochloride, 1.5-1.75 mL 30% sodium hydroxide solution, 1-1.17 mmol 4-((6-bromo-9-ethyl-9H-carbazole-3-yl)methylene)-2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]heptan-3-one, and 6-7 mL dimethyl sulfoxide were sequentially added into a 50 mL dry three-necked flask and heated under reflux for reaction for 12 h; (2) After the reaction solution is cooled to room temperature, ethyl acetate is added, and the mixture is washed with saturated brine until neutral. The organic phase is dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product of 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol; (3) The crude product of 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol was separated by silica gel column (ethyl acetate / petroleum ether=1 / 1, v / v) to obtain 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol.

5. The method for synthesizing the 2-hydroxy-3-pinonyl pyrimidine pH-sensitive fluorescent probe according to claim 2, characterized in that: In step 3), the specific preparation method of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxypropyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-oxomethylenequinazoline-8-ol is as follows: (1) 2-2.4 mmol 4-(6-bromo-9-ethyl-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol, 6-7.2 mmol 4-pyridineboric acid, 0.2-0.24 mmol tetrakis(triphenylphosphine)palladium, 9-10.8 mmol potassium carbonate, and 50-60 mL 1,4-dioxane / water solution were sequentially added into a 100 mL dry three-necked flask, and heated under reflux for reaction for 20 h under nitrogen protection; (2) After the reaction solution was distilled under reduced pressure to remove 1,4-dioxane / water solution, ethyl acetate was added, and the mixture was washed with saturated brine until neutral. The organic phase was dried over anhydrous sodium sulfate, filtered, and concentrated to obtain a crude product of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol; (3) The crude product of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol was separated by silica gel column (dichloromethane / methanol=35 / 1, v / v) to obtain 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol.

6. Use of 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-methanoquinazolin-8-ol as claimed in claim 1 in a fluorescent probe.

7. The use according to claim 6, characterized in that The compound 4-(9-ethyl-6-(pyridin-4-yl)-9H-carbazole-3-yl)-2-(4-hydroxyphenyl)-6,6,8-trimethyl-5,6,7,8-tetrahydro-5,7-bridged methylquinazoline-8-ol can specifically recognize acidic pH and alkaline pH. Under acidic conditions, as the pH value in the system continues to decrease, the fluorescence color of the solution changes from blue to yellow; under alkaline conditions, as the pH value in the system continues to increase, the blue fluorescence of the solution gradually weakens. The compound can be used as a fluorescent probe for measuring pH, has many advantages such as convenient synthesis, good selectivity, high sensitivity, etc., and has good application prospects.

Citation Information

Patent Citations

  • Carbazole type pH fluorescence probe and preparation method and application thereof

    CN104531139A

  • Substituted imidazo[1,2-a] pyridine type pH florescence probe and application thereof

    CN108503635A

  • Ratio-type fluorescent probe for detecting acidic pH value as well as preparation method and application of ratio-type fluorescent probe

    CN114163422A